Werfen, officially known as Werfen Group, is a leading global player in the medical diagnostics industry, headquartered in Barcelona, Spain. Founded in 1966, the company has established a strong presence in key operational regions, including Europe, North America, and Asia-Pacific. Specialising in in vitro diagnostics, Werfen focuses on areas such as haemostasis, acute care, and immunoassay testing. Their innovative products, including advanced diagnostic instruments and reagents, are designed to enhance patient care and streamline laboratory workflows. With a commitment to quality and precision, Werfen has achieved significant milestones, positioning itself as a trusted partner in healthcare. The company is recognised for its robust market presence and dedication to advancing diagnostic solutions, making it a prominent name in the industry.
How does Werfen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Werfen's score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Werfen reported total carbon emissions of approximately 88,000,000 kg CO2e, comprising 3,271,000 kg CO2e from Scope 1, 1,354,000 kg CO2e from Scope 2, and 85,403,000 kg CO2e from Scope 3 emissions. This data reflects a comprehensive assessment of their carbon footprint across all relevant scopes. In 2021, Werfen's emissions in the UK were significantly lower, totalling approximately 582,150 kg CO2e, with Scope 1 emissions at 271,710 kg CO2e, Scope 2 at 1,890 kg CO2e, and Scope 3 at 308,550 kg CO2e. This indicates a substantial increase in emissions from 2021 to 2024, particularly in Scope 3, which is often the largest contributor to total emissions for many organisations. Despite the increase in emissions, there are currently no publicly disclosed reduction targets or initiatives from Werfen, nor are there any commitments to the Science Based Targets initiative (SBTi) or similar frameworks. This lack of formal climate commitments may reflect an industry context where many companies are still developing their sustainability strategies. Werfen's emissions data is not cascaded from a parent company, indicating that the figures are independently reported by Werfen, S.A. As the company continues to assess its environmental impact, future commitments and reduction strategies may be essential for aligning with global climate goals.
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 3,271,000 |
| Scope 2 | 1,354,000 |
| Scope 3 | 85,403,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Werfen has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

